SATIVEX

Sativex is indicated for symptom improvement in adult patients with moderate to severe spasticity due to multiple sclerosis who have not adequately responded to other anti-spasticity medication and who demonstrate clinically significant improvement in spasticity-related symptoms during an initial trial of therapy.